- Published:
The Use of Atropine to Control Heart Rate Responses During Detomidine Sedation in Horses
Användning av atropin för att kontrollera hjärtfrekvensen vid detomidinbehandling på häst
Acta Veterinaria Scandinavica volume 27, pages 548–559 (1986)
Abstract
Detomidine is a sedative-analgesic which has a pharmacological profile similar to xylazine. There is evidence that the sedative effects are mediated through alpha-2 adrenoceptors.
Cardiopulmonary responses were determined using detomidine as the principal agent and as a preanesthetic prior to the induction of general anesthesia. Compatibility with guaifenesin, sodium thia-mylal and halothane were determined.
As in the case of xylazine, detomidine produces a slowing of heart rates. This was found to be either sinus bradycardia or heart block. There may be a corresponding increase in systolic blood pressures. The respiratory pattern is altered through the arterial blood gases and pH data supported evidence of adequate ventilation. The heart rate response to detomidine without anticholinergic treatment was transient and related to he duration of drug action.
Atropine sulfate, 0.02 mg/kg i.v. was effective in preventing or treating bradycardia or heart block from detomidine. Heart rates also increased during the administration of guaifenesin and sodium thia-mylal when given 50 min poisit-detomidine.
Sammanfattning
Detomidin är ett sedativt analgetikum med en farmakologisk profil lik xylazinets. De sedativa effekterna medieras uppenbarligen genom alfa-2 adrenoreceptorer.
De kardiopulmonära effekterna av detomidin studerades med detomidin som den principiella faktorn och som ett preanestetikum före induktion av allmän anestesi med guaifenesin, natrium thiamylal och halotan.
I likhet med xylazin förorsakar detomidin bradykardi, vilken befanns vare antingen sinus-bradykardi eller hjärtblock. En motsvarande ökning i systoliskt blodtryck kan inträffa. Respirationen kan vara förändrad även om arteriella blodgaser och pH tyder på adekvat ventilation. Effekten på hjärtfrekvensen av detomidin utan antikolinergisk behandling var tillfällig och berodde på längden av detomidinets verkan.
Intravenös applicering av atropinsulfat, 0,02 mg/kg, förhindrade effektivt den av detomidin förorsakade bradykardin eller hjärtblocket. Hjärtfrekvensen ökade också efter administrering av guaifenesin och natrium thiamylal 30 min efter detomidin.
References
Alitalo, L., O. Vainio, L. Kaartinen & M. Raekallio: Cardiac effects of Atropine premedication in horses sedated with Detomidine. Acta vet. scand. 1986, Suppl. 82, 131–136.
Clarke, K. W. & L. W. Hall: Xylazine–a new sedative for horses and cattle. Vet. Rec, 1969, 85, 512–517.
Clough, D. P. & R. Hatton: Hypotensive and sedative effects of α-adrenoceptor agonists: relationshop to α2- and α2-adrenoceptor potency. Brit. J. Pharmacol. 1981, 73, 595–604.
Delbarre, B. & H. Schmitt: Sedative effects of sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur. J. Pharmacol. 1971, 13, 356–363.
Delini-Stula, A., P. Baumann & O. Buch: Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central adrenergic receptor selectivity of α-adrenolytic drugs. Naunyn-Schmiedebeirg’s Arch. Pharmacol. 1979, 307, 115–122.
Hsu, W. S.: Xylazine-induced depression anid its antagonism by alpha adrenergic blocking agents. J. Pharmacol, exp. Ther. 1981, 218, 188–192.
Kalpravidh, M., W. V. Lumb, M. Wright & R. B. Heath: Effects of butorphanol, flunixin, levorphanol, morphine and xylazine in ponies. Amer. J. vet. Res. 1984a, 45, 217–223.
Kalpravidh, M., W. V. Lumb, M. Wright & B. B. Heath: Analgesic effects of butorphanol in horses: Dose-response studies. Amer. J. vet. Res. 1984b, 45, 211–216.
Kerr, D. D., E. W. Jones, K. Huggins & W. C. Edwards: Sedative and other effects of xylazine given intravenously to horses. Amer. J. vet. Res. 1972, 33, 525–532.
Klein, L. V. & C. Baetjer: Preliminary report: Xylazine and morphine sedation in horses. Vet. Anesth. 1974, 1, 2–6.
Muir, W. W., R. T. Skarda & W. C. Sheehan: Hemodynamic and respiratory effects of xylazine-morphine sulfate in horses. Amer. J. vet. Res. 1979, 40, 1417–1420.
Robertson, J. T., W. W. Muir & R. Sams: Cardiopulmonary effects of butorphanol tartrate in horses. Amer. J. vet. Res. 1981, 42, 41–44.
Short, C. E., N. Matthews, R. Harvey & C. L. Tyner: Cardiovascular and pulmonary function studies of a new sedative analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic. Acta vet. scand. 1986, Suppl. 82, 139–155.
Vainio, O.: Detomidine hydrochloride. A novel imidazole-type sedative analgesic. In: Veterinary Pharmacology and Toxicology. Eds. T. Ruckebusch, P. L. Toutain and G. D. Horitz, MTP Press Limited, Lancaster 1983, p. 798–799.
van Zwieten, P. A., M. J. M. C. Thoolen & P. B. M. W. M. Timmermans: The pharmacology of centrally acting antihypertensive drugs. Brit. J. clin. Pharmacol 1983, 15, 455S–462S.
Virtanen, R., H. Ruskoaho & L. Nyman: Pharmacological evidence for the involvement of alpha-2 adrenoceptors in the sedative effect of detomidine, a novel sedative-analgesic. J. vet. Pharmacol. Ther. 1985, 8, 30–37.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Short, C.E., Stauffer, JL., Goldberg, G. et al. The Use of Atropine to Control Heart Rate Responses During Detomidine Sedation in Horses. Acta Vet Scand 27, 548–559 (1986). https://doi.org/10.1186/BF03548134
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03548134